Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction. https://t.co/VwTzE9ZsdI

RT @NatRevUrol: A great Review from @TheLancetInfDis on optimising therapy for STIs https://t.co/fVgRxamSaE

A great Review from @TheLancetInfDis on optimising therapy for STIs https://t.co/fVgRxamSaE

RT @SOGALCA: Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic st…

RT @STIRIG_LSHTM: Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria go…

RT @STD_Journal: Addressing the global #STI requires better surveillance of antibiotic resistance, new antibiotics, more point-of-care test…

RT @STIRIG_LSHTM: Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria go…

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction - The Lancet Infectious Diseases #PtSafety https://t.co/I8nrg0w88m

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction - The Lancet Infectious Diseases #PtSafety https://t.co/HdH7AK0zgk

RT @STD_Journal: Addressing the global #STI requires better surveillance of antibiotic resistance, new antibiotics, more point-of-care test…

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction https://t.co/TNi2Je3I5n

RT @STIRIG_LSHTM: Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria go…

RT @STIRIG_LSHTM: Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria go…

RT @STIRIG_LSHTM: Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria go…

RT @STD_Journal: Addressing the global #STI requires better surveillance of antibiotic resistance, new antibiotics, more point-of-care test…

RT @STIRIG_LSHTM: Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria go…

Review highlighting urgent needs in global STI management in light of increasing antimicrobial resistance in Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis. #STI #STIs #AMR #NG #MG #TV #gonorrhoea

No esta libre..es de pago!!

Addressing the global #STI requires better surveillance of antibiotic resistance, new antibiotics, more point-of-care testing, vaccines and better pharmacokinetic data. From our colleagues ⁦@SenaChat⁩ @LauraBachmann13⁩ ⁦@CJohnston_MD⁩ https://t.co/TDgDW

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction https://t.co/ygtWNjEDz7

RT @TheLancetInfDis: New Review: Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodyna…

RT @TheLancetInfDis: New Review: Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodyna…

RT @TheLancetInfDis: New Review: Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodyna…

RT @TheLancetInfDis: New Review: Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodyna…

New Review: Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction https://t.co/YtN6ZjJWWr #STI

RT @drjanenicholls: URGENT ⤵️ ➡️ improved surveillance to monitor AMR & clinical outcomes ➡️ systematic pharmacokinetic & pharmacodynamic…

RT @LancetMicrobe: New ⁦@TheLancetInfDis⁩ review> Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics…

RT @drjanenicholls: URGENT ⤵️ ➡️ improved surveillance to monitor AMR & clinical outcomes ➡️ systematic pharmacokinetic & pharmacodynamic…

RT @drjanenicholls: URGENT ⤵️ ➡️ improved surveillance to monitor AMR & clinical outcomes ➡️ systematic pharmacokinetic & pharmacodynamic…

RT @drjanenicholls: URGENT ⤵️ ➡️ improved surveillance to monitor AMR & clinical outcomes ➡️ systematic pharmacokinetic & pharmacodynamic…

URGENT ⤵️ ➡️ improved surveillance to monitor AMR & clinical outcomes ➡️ systematic pharmacokinetic & pharmacodynamic evaluations to ensure resistance suppression ➡️ development of novel affordable antimicrobials ➡️ advancements in new molecular &

New ⁦@TheLancetInfDis⁩ review> Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction #STIs https://t.co/L1a8WiT9wW